• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯贝丁酯治疗对肝脏前列腺素分解代谢及作用的影响。

Effect of clofibrate treatment on hepatic prostaglandin catabolism and action.

作者信息

Brass E P, Ruff L J

机构信息

Department of Medicine, Case Western Reserve University, Cleveland, Ohio.

出版信息

J Pharmacol Exp Ther. 1991 Jun;257(3):1034-8.

PMID:2046019
Abstract

Prostaglandins (PG) modulate hepatocyte glucose and lipid metabolism. Hepatocytes rapidly metabolize PG via beta-oxidation, terminating PG action. Clofibrate induces hepatic peroxisomal beta-oxidative activity, for which PG are substrates. To determine the effect of clofibrate-treatment on liver PG metabolism and action, hepatocytes were isolated from rats maintained on a control or clofibrate-supplemented (0.5%) diet for 7 to 9 days. Rates of PG catabolism were determined by high performance liquid chromatography resolution of [3H]PG from [3H]metabolites. Clofibrate treatment enhanced the rates of PGE2, PGF2, and PGD2 degradation by 85%, 278% and 137%, respectively. Rates of PG degradation were correlated with hepatocyte carnitine acetyltransferase activity, a marker of peroxisomal proliferation. Further evidence of enhanced hepatocyte peroxisomal beta-oxidation of PG after clofibrate-treatment was obtained by confirming loss of the 1-position carbon from [1-14C]PGE2 during PGE2 metabolism and failure of the carnitine acyltransferase inhibitor acetyl-DL-aminocarnitine to inhibit PGE2 metabolism. Associated with the faster degradation of PGE2 by hepatocytes from clofibrate-treated rats was loss of inhibition of hepatocyte glucagon-stimulated glycogenolysis by exogenous PGE2. Thus, clofibrate's induction of peroxisomal beta-oxidation is associated with accelerated catabolism of PG and decreased PG action. Alterations in PG breakdown provide a mechanism for modulating hepatic PG effects.

摘要

前列腺素(PG)可调节肝细胞的葡萄糖和脂质代谢。肝细胞通过β-氧化迅速代谢PG,从而终止PG的作用。氯贝丁酯可诱导肝脏过氧化物酶体β-氧化活性,而PG是该氧化过程的底物。为了确定氯贝丁酯治疗对肝脏PG代谢及作用的影响,从分别以对照饮食或添加氯贝丁酯(0.5%)饮食喂养7至9天的大鼠中分离肝细胞。通过高效液相色谱法从[³H]代谢产物中分离[³H]PG来测定PG分解代谢率。氯贝丁酯治疗分别使PGE₂、PGF₂和PGD₂的降解率提高了85%、278%和137%。PG降解率与肝细胞肉碱乙酰转移酶活性相关,肉碱乙酰转移酶是过氧化物酶体增殖的标志物。通过确认PGE₂代谢过程中[¹-¹⁴C]PGE₂的1位碳原子丢失以及肉碱酰基转移酶抑制剂乙酰-DL-氨基肉碱未能抑制PGE₂代谢,获得了氯贝丁酯治疗后肝细胞PG过氧化物酶体β-氧化增强的进一步证据。与氯贝丁酯治疗大鼠的肝细胞对PGE₂降解加快相关的是,外源性PGE₂对肝细胞胰高血糖素刺激的糖原分解的抑制作用丧失。因此,氯贝丁酯诱导的过氧化物酶体β-氧化与PG分解代谢加速和PG作用减弱有关。PG分解的改变为调节肝脏PG效应提供了一种机制。

相似文献

1
Effect of clofibrate treatment on hepatic prostaglandin catabolism and action.氯贝丁酯治疗对肝脏前列腺素分解代谢及作用的影响。
J Pharmacol Exp Ther. 1991 Jun;257(3):1034-8.
2
Inhibition of prostaglandin E2 catabolism and potentiation of hepatic prostaglandin E2 action in rat hepatocytes by inhibitors of oxidative metabolism.氧化代谢抑制剂对大鼠肝细胞中前列腺素E2分解代谢的抑制及肝前列腺素E2作用的增强
Biochem Pharmacol. 1988 Apr 1;37(7):1343-9. doi: 10.1016/0006-2952(88)90792-7.
3
Structural specificity for prostaglandin effects on hepatocyte glycogenolysis.前列腺素对肝细胞糖原分解作用的结构特异性。
Biochem J. 1990 Apr 1;267(1):59-62. doi: 10.1042/bj2670059.
4
Clofibrate does not induce peroxisomal 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholestanoyl coenzyme A oxidation in rat liver. Evidence that this reaction is catalyzed by an enzyme system different from that of peroxisomal acyl-coenzyme A oxidation.氯贝丁酯不会诱导大鼠肝脏中过氧化物酶体3α,7α,12α-三羟基-5β-胆甾烷酰辅酶A氧化。有证据表明,该反应由不同于过氧化物酶体酰基辅酶A氧化酶系统的酶系统催化。
Biochem Int. 1988 Jul;17(1):163-9.
5
Beta-oxidation of the carboxyl side chain of prostaglandin E2 in rat liver peroxisomes and mitochondria.前列腺素E2羧基侧链在大鼠肝脏过氧化物酶体和线粒体中的β-氧化作用。
J Biol Chem. 1988 Feb 25;263(6):2724-31.
6
Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.在CD大鼠中给予氯贝丁酯、吉非贝齐或苯扎贝特后肝微粒体酶诱导、β-氧化和细胞增殖情况
Toxicol Appl Pharmacol. 1997 Jan;142(1):143-50. doi: 10.1006/taap.1996.8007.
7
[Effect of clofibrate on the polypeptide content of a purified fraction of rat liver peroxisomes].
Biokhimiia. 1983 Sep;48(9):1429-36.
8
Liver peroxisomal fatty acid oxidizing system during aging in control and clofibrate-treated mice.
Biochem Mol Biol Int. 1995 Oct;37(3):475-80.
9
Feedback-inhibition of glucagon-stimulated glycogenolysis in hepatocyte/Kupffer cell cocultures by glucagon-elicited prostaglandin production in Kupffer cells.
Hepatology. 1995 Nov;22(5):1577-83.
10
Effects of clofibrate withdrawal on peroxisomes in mouse hepatocytes.
Eur J Cell Biol. 1993 Apr;60(2):291-9.

引用本文的文献

1
Altered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid.用过氧化物酶体增殖剂环丙贝特和全氟癸酸处理的大鼠肝脏类花生酸浓度的改变
Arch Toxicol. 1995;69(7):491-7. doi: 10.1007/s002040050203.
2
Interleukin-6, but not tumour necrosis factor-alpha, increases lipogenesis in rat hepatocyte primary cultures.白细胞介素-6而非肿瘤坏死因子-α可增加大鼠原代肝细胞培养中的脂肪生成。
Biochem J. 1994 Jul 1;301 ( Pt 1)(Pt 1):193-7. doi: 10.1042/bj3010193.
3
Translation rates of isolated liver mitochondria under conditions of hepatic mitochondrial proliferation.
肝脏线粒体增殖条件下分离的肝线粒体的翻译速率。
Biochem J. 1992 Nov 15;288 ( Pt 1)(Pt 1):175-80. doi: 10.1042/bj2880175.